Table 3 Clinicopathological features of 33 patients with pancreatic serous cystadenoma with or without Pax8 expression
Features | Variables | No Pax8 expression (number, %) | Pax8 expression (number, %) | P value |
|---|---|---|---|---|
Age (mean, range) | 63 years (23–87) | 64 years (23–87) | 53 years (43–66) | 0.07 |
Gender | Male | 8 (80%) | 2 (20%) | 0.91 |
Female | 18 (78%) | 5 (22%) | ||
Location | Head | 7 (88%) | 1 (13%) | 0.84 |
Body | 12 (75%) | 4 (20%) | ||
Distal | 6 (75%) | 2 (25%) | ||
Diffuse | 1 (100%) | 0 | ||
Cyst fluid CEA level (n = 11) | Normal (< 5 ng/mL) | 8 (89%) | 1 (11%) | 0.20 |
Elevated (> = 5 ng/mL) | 1 (50%) | 1 (50%) | ||
Cyst types | Microcystic | 19 (73%) | 7 (27%) | 0.12 |
Macrocytic/oligocystic | 7 (100%) | 0 | ||
von Hippel-Lindau syndrome | Yes | 4 (67%) | 2 (33%) | 0.42 |
No | 22 (81%) | 5 (19%) |